Most Popular

Apple Inc. (AAPL) & Microsoft Corporation (MSFT) Top List Of World’s Most Valuable Brands

The value of technology is never something to underestimate. Whether it is a quality-made product that is used every day or a service …

Top-Ranked Analysts Are Bullish on Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) has been a favorite among biotech investors due to its successful hepatitis C therapies; Harvoni and Sovaldi.

King Digital Entertainment PLC (KING) Isn’t The One Hit Wonder You Think It Is

King Digital Entertainment PLC (NYSE:KING) is set to report first quarter earnings Thursday after the closing bell. The latest installment in King’s flagship …

Insider Selling News: LinkedIn Corp (LNKD), Yelp Inc (YELP), Insmed Incorporated (INSM), salesforce.com, inc. (CRM)

Recently, various executives have taken part in insider selling activity for the stocks of LinkedIn Corp (NYSE:LNKD), Yelp Inc (NYSE:YELP), Insmed Incorporated (NASDAQ:INSM), …

Oppenheimer Weighs in on Biotech Stocks: Opko Health Inc. (OPK) & OvaScience Inc (OVAS)

Rohit Vanjani of Oppenheimer rates stocks in the biotechnology sector and is one of the top 25 analysts rated on TipRanks. Yesterday, Vanjani made …

Will Gilead Sciences, Inc (GILD) Acquire Vertex Pharmaceuticals Incorporated (VRTX) Despite its Short-Term Dominance In Cystic Fibrosis?

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) weekly options are pricing in a move of +/- $10 with Implied VOL currently in the 28th percentile over the …

Tuesday Pre-Market Insights: Threshold Pharmaceuticals, Inc. (THLD), Pall Corporation (PLL), AOL, Inc. (AOL), magicJack VocalTec Ltd (CALL)

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) increased more than 26% in pre-market trading to $4.

Analysts are Positive on Intercept Pharmaceuticals Inc (ICPT) Following Quarterly Earnings and Pipeline Update

On May 11, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) reported first quarter earnings for 2015. The biopharmaceutical company does not yet have any approved products …

MannKind Corporation (MNKD): Afrezza Prescriptions Picking Up

MannKind Corporation (NASDAQ:MNKD) released its latest earnings report on May 8, and Wall Street was generally disappointed. However, not everyone is so bearish …

Brean Capital Offers Commentary on Inovio Pharmaceuticals Inc Following 1Q:15 Update

In a research report issued today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Inovio Pharmaceuticals Inc (NASDAQ:INO) with a $20 price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts